Home
>
National Drug Code (NDC)
>
Ropinirole
Ropinirole - 0054-0117-25 - (rOPINIRole)
Drug Information of Ropinirole
| Product NDC: | 0054-0117 |
| Proprietary Name: | Ropinirole |
| Non Proprietary Name: | rOPINIRole |
| Active Ingredient(s): | .5 mg/1 & nbsp; rOPINIRole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ropinirole
| Product NDC: | 0054-0117 |
| Labeler Name: | Roxane Laboratories, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077852 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080505 |
Package Information of Ropinirole
| Package NDC: | 0054-0117-25 |
| Package Description: | 100 TABLET in 1 BOTTLE (0054-0117-25) |
NDC Information of Ropinirole
| NDC Code | 0054-0117-25 |
| Proprietary Name | Ropinirole |
| Package Description | 100 TABLET in 1 BOTTLE (0054-0117-25) |
| Product NDC | 0054-0117 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rOPINIRole |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080505 |
| Marketing Category Name | ANDA |
| Labeler Name | Roxane Laboratories, Inc |
| Substance Name | ROPINIROLE HYDROCHLORIDE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |
